BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/16/2023 4:00:12 AM | Browse: 214 | Download: 473
 |
Received |
|
2023-02-24 05:31 |
|
Peer-Review Started |
|
2023-02-24 05:35 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-03-14 13:02 |
|
Revised |
|
2023-03-20 11:54 |
|
Second Decision |
|
2023-04-14 03:18 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2023-04-14 09:55 |
|
Articles in Press |
|
2023-04-14 09:55 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2023-04-13 22:27 |
|
Typeset the Manuscript |
|
2023-06-12 01:39 |
|
Publish the Manuscript Online |
|
2023-06-16 04:00 |
| ISSN |
2308-3840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Minireviews |
| Article Title |
Advances in the mechanism of action of metformin in pituitary tumors
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Long-Yao Zhang, Yu-Hua Yin and Xue-Jian Wang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the Science and Technology Program of Nantong Health Committee |
MA2019003 |
| the Science and Technology Program of Nantong Health Committee |
MA2021017 |
| the Science and Technology Program of Nantong Health Committee |
MB2021026 |
| the Science and Technology Program of Nantong Health Committee |
MB2021027 |
| Science and Technology Program of Nantong City |
Key003 |
| Science and Technology Program of Nantong City |
JCZ2022040 |
| Kangda College of Nanjing Medical University |
KD2021JYYJYB025 |
| Kangda College of Nanjing Medical University |
KD2022KYFZZD025 |
|
| Corresponding Author |
Xue-Jian Wang, MD, PhD, Professor, Surgeon, Department of Neurosurgery, Affiliated Hospital 2 to Nantong University, No. 666 Victory Road, Chongchuan District, Nantong 226000, Jiangsu Province, China. 6841441@163.com |
| Key Words |
Metformin; Pituitary tumor; Mechanism; Treatment; Study; Review |
| Core Tip |
Pituitary tumors are common intracranial tumors, but when faced with drug-resistant or aggressive tumors, existing medical measures may not provide good control, leading to progression and deterioration. Metformin, a traditional hypoglycemic drug, has recently been discovered to have multiple functions including antitumor effects. There have been studies on the mechanism of metformin for the treatment of pituitary tumors, but it is uncertain whether it will provide new adjuvant or alternative therapies for the treatment of these tumors. We analyzed the potential mechanisms of action of metformin on the inhibition of pituitary tumor growth and hormone secretion by reviewing the available literature. |
| Publish Date |
2023-06-16 04:00 |
| Citation |
Zhang LY, Yin YH, Wang XJ. Advances in the mechanism of action of metformin in pituitary tumors. World J Meta-Anal 2023; 11(5): 144-150 |
| URL |
https://www.wjgnet.com/2308-3840/full/v11/i5/144.htm |
| DOI |
https://dx.doi.org/10.13105/wjma.v11.i5.144 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
